This page is being served from the Urological Sciences Research Foundation web repository, and was originally posted between 1996-2008. In January 2009 USRF’s founder, Dr. Leonard S. Marks and his staff joined UCLA’s Department of Urology where they are continuing their research. Click for more information.
Recalls | Site map | Search | Help/FAQs
Subscribe | E-mail | CR products & services
Clinical testing has now begun to catch up with saw palmetto's popularity. Results show that early 20th-century physicians were onto something when they used infusions and potions made from the fruit of the southeastern U.S. palm plant for male genital and urinary problems.
Saw palmetto has had an off-and-on relationship with official listings of plant and pharmaceutical medicines by the United States Pharmacopeia (USP) and its National Formulary (NF). The berry was included as a medicine for prostate problems in the first half of the 20th century, dropped by the 1950s, and reinstated just this year. An April 2000 USP monograph concluded that clinical trials of saw palmetto "provide evidence of moderate scientific quality that commercial extracts of saw palmetto ... are more effective than a placebo in relieving lower-urinary-tract symptoms of BPH [benign prostatic hyperplasia, or noncancerous enlargement of the gland]." The report also found that the herbal remedy has no significant side effects and only rarely causes mild stomach upset or diarrhea. (However, it noted that drug interactions and medical contraindications have not yet been studied adequately.)
Now that the report has been published, manufacturers who voluntarily meet USP's standards of potency and purity may place the USP's "NF" seal on their labels.
But unlike modern pharmaceuticals, made with chemicals in a lab, plant-based medicines are notoriously difficult to standardize. Individual plants can vary greatly in their content of key active chemicals. And consumers have virtually no protection against inaccurate labeling or substandard preparation, because of a lack of meaningful government regulation of herbal products.
For that reason, Consumers Union is expanding its herbal-testing program. Over the next few years, working with outside labs that specialize in testing herbal products, we will test representative brands of herbal remedies that are performing well in clinical trials. Our ingredient testing will follow our usual standards, which include anonymous shopping at a variety of retail outlets and, for many products, the testing of several samples of each brand, obtained from different parts of the country.
Of the 13
saw-palmetto brands tested for this report, we found that only 8 had the
right amount of the right stuff: The number of pills recommended on the
label did supply the desirable amount of berry extract, at prices ranging
from 44 cents to $1.44 a day. The other 5 brands fell short--often woefully
short, with the recommended pills supplying as little as 1 percent of
the desirable daily dosage (see What
the brands contain).
BPH is generally not a dangerous condition, but individuals bothered by any of those urinary symptoms should see a doctor to rule out other diseases such as diabetes, prostate or bladder infection, neurologic disorders, and cancer. If the problem is BPH, a doctor can help you decide whether to treat it, and if so, how.
BPH sometimes improves spontaneously. The decision on what to do--watchful waiting or treatment with saw palmetto, prescription medicine, or surgery--should be driven by how bothersome your symptoms are. If the problem is mild, watchful waiting may be all you need. That means seeing the doctor for regular checkups and taking such steps as limiting evening intake of fluids, particularly alcohol and coffee. Make sure to ask the doctor whether any drugs you're taking--especially diuretics (water pills), antihistamines, decongestants, antidepressants, and tranquilizers--might be aggravating the problem.
men whose sleep is continually disrupted by the frequent need to urinate
at night or whose lifestyle is circumscribed by having to stay within
dashing distance of a bathroom should consider treatment.
Most clinical trials have tested saw palmetto against a placebo, not against a prescription drug. In 1998 the Journal of the American Medical Association published a review of 18 such clinical trials. The review, by researchers at the Minneapolis VA Medical Center and other institutions, concluded that the evidence points in saw palmetto's favor. Overall, about three-quarters of BPH patients taking the herb reported an improvement in symptoms, compared with about half of those on placebo. (Such a strong placebo response is not uncommon in clinical trials, particularly if the disorder waxes and wanes.) Moreover, saw palmetto appears to relieve several types of symptoms: It boosted the strength of the urine stream, allowed more-complete emptying of the bladder, and reduced the number of nighttime trips to the bathroom. Those benefits added up to a 37 percent improvement in urinary symptoms.
In the world of herbal medicines, where research is usually scanty, that evidence is rather impressive. But it still falls short of what's usually required for drug approval by the Food and Drug Administration (FDA). The clinical trials have typically lasted only six months or less, while prescription prostate drugs have proved their safety and efficacy in studies lasting up to six years. The American Urological Association (AUA), which represents urologists, says it's keeping an open mind while awaiting the outcome of longer clinical trials, including a one-year placebo-controlled study of saw palmetto funded by the National Institutes of Health.
me is that we don't know about drug interactions," says H. Logan Holtgrewe,
M.D., chairman of the AUA's health-care policy committee. In contrast,
he says, "we have two families of medications that have been shown efficacious
based on good evidence from prospective, randomized, blinded clinical
Finasteride shrinks the prostate by decreasing production of DHT. It works best in the minority of patients with BPH whose gland is greatly enlarged. Few studies have compared finasteride with saw palmetto. But in one six-month trial of more than 1,000 BPH patients, the drug increased urinary flow by 30 percent, while the herbal remedy boosted flow by a comparable 25 percent. What's more, the herbal did not cause the most troublesome side effect of finasteride: erectile dysfunction in about 9 percent of men. And unlike the drug, saw palmetto doesn't interfere with the standard prostate specific antigen (PSA) cancer-screening test. However, the study was too short to draw definite conclusions, since saw palmetto's effects typically kick in within one to two months, whereas finasteride's sometimes take more than six months.
most physicians feel that finasteride's main role in the treatment of
BPH is the long-term prevention of complications, such as complete bladder
blockage, and of progression to surgery," says Michael Barry, MD, chief
of the general medicine unit at Massachusetts General Hospital in Boston.
"There's no evidence that saw palmetto conveys that benefit."
In clinical trials, alpha-blockers have reduced symptoms faster and better than finasteride, although we could find no published data on whether they prevent long-term complications. One published study found that saw palmetto relieved symptoms almost as effectively as an alpha-blocker, but the USP's reviewers concluded that the study was too loosely designed to draw reliable conclusions.
In the recent Consumer Reports survey, readers with benign prostate problems rated prescription medications, presumably including alpha-blockers, more effective than saw palmetto. As our tests suggest, however, some of those readers probably took pills that supplied relatively small doses of saw palmetto.
Overall, a few points do seem clear. Alpha-blockers work faster than saw palmetto, starting to relieve symptoms in as little as one week. But alpha-blockers, particularly doxazosin and terazosin, can cause reduced blood pressure, necessitating careful monitoring with frequent blood-pressure checks.
doctors are starting to recommend saw palmetto for patients with mild
symptoms--or at least not flinch when patients want to try it--others
are unenthusiastic. Claus Roehrborn, M.D., an associate professor of urology
at the University of Texas Southwestern Medical Center in Dallas, considers
saw palmetto "nothing but junk food." That's because the FDA regulates
herbals as foods, not drugs.
As our tests indicate, makers of some saw-palmetto products need to do a better job of producing standardized, properly labeled products. And the FDA should act on its promise to define good manufacturing practices for nutritional supplements.
Men with troublesome BPH symptoms that don't respond to evening fluid restriction, drug-regimen changes, and possibly saw palmetto should turn to prescription prostate medication. Because alpha-blockers work so rapidly, they're usually worth trying before finasteride, especially for men with intermittent urinary flow and no more than moderate prostate enlargement. If alpha-blockers don't work, doctors can prescribe finasteride for men with a very large prostate. If all else fails, paring down the prostate via surgery or one of several other invasive techniques can be considered. The latest and best study suggests that those methods do not increase the risks of incontinence or impotence, although some may cause infertility.
|Home | Magazine | Ratings/Reports | Forums | Product safety | Recalls
Site map | Search | Help/FAQs | Subscribe | E-mail | CR products & services
|Copyright © Consumers Union of U.S., Inc., 2000